🇺🇸 FDA
Patent

US 9957324

Anti-FLT-1 antibodies in treating duchenne muscular dystrophy

granted A61KA61K2039/505A61P

Quick answer

US patent 9957324 (Anti-FLT-1 antibodies in treating duchenne muscular dystrophy) held by Regents of the University of Minnesota expires Mon Apr 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regents of the University of Minnesota
Grant date
Tue May 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K2039/505, A61P, A61P1/00, A61P11/00